computer
WHO/MSD/MSB 00.2g
Workbook 6
Client
Satisfaction
Evaluations
Workbook 6 · Clent Satisfaction Evaluations
1
WHO/MSD/MSB 00.2g
c
World Health Organization, 2000
WHO
World Health Organization
UNDCP
United Nations International Drug Control Programme
EMCDDA
European Monitoring Center on Drugs and Drug Addiction
This document is not a formal publication of the World Health Organization (WHO) and all rights are reserved by the
Organization. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole but not for sale nor for use in conjunction with commercial purposes. The views expressed in documents by named authors are solely the responsibility of those authors.
2
Evaluation of Psychoactive Substance Use Disorder Treatment
WHO/MSD/MSB 00.2g
Acknowledgements
The World Health Organization gratefully acknowledges the contributions of the numerous individuals involved in the preparation of this workbook series, including the experts who provided useful comments throughout its preparation for the Substance Abuse Department, directed by Dr. Mary Jansen. Financial assistance was provided by
UNDCP/EMCDDA/Swiss Federal
Office of Public Health. Cam Wild
(Canada) wrote the original text for this workbook and Brian Rush
Workbook 6 · Clent Satisfaction Evaluations
(Canada) edited the workbook series in earlier stages. JoAnne EppingJordan (Switzerland) wrote further text modifications and edited the workbook series in later stages.
Munira Lalji (WHO, Substance
Abuse Department) and Jennifer
Hillebrand (WHO, Substance Abuse
Department) also edited the workbook series in later stages. Maristela
Monteiro (WHO, Substance Abuse
Department) provided editorial input throughout the development of this workbook. 3
WHO/MSD/MSB 00.2g
4
Evaluation of Psychoactive Substance Use Disorder Treatment
WHO/MSD/MSB 00.2g
Table of contents
Overview of
Workbook 6
Client
Satisfaction
Evaluations
Workbook 6 · Clent Satisfaction Evaluations
1
WHO/MSD/MSB 00.2g
c
World Health Organization, 2000
WHO
World Health Organization
UNDCP
United Nations International Drug Control Programme
EMCDDA
European Monitoring Center on Drugs and Drug Addiction
This document is not a formal publication of the World Health Organization (WHO) and all rights are reserved by the
Organization. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole but not for sale nor for use in conjunction with commercial purposes. The views expressed in documents by named authors are solely the responsibility of those authors.
2
Evaluation of Psychoactive Substance Use Disorder Treatment
WHO/MSD/MSB 00.2g
Acknowledgements
The World Health Organization gratefully acknowledges the contributions of the numerous individuals involved in the preparation of this workbook series, including the experts who provided useful comments throughout its preparation for the Substance Abuse Department, directed by Dr. Mary Jansen. Financial assistance was provided by
UNDCP/EMCDDA/Swiss Federal
Office of Public Health. Cam Wild
(Canada) wrote the original text for this workbook and Brian Rush
Workbook 6 · Clent Satisfaction Evaluations
(Canada) edited the workbook series in earlier stages. JoAnne EppingJordan (Switzerland) wrote further text modifications and edited the workbook series in later stages.
Munira Lalji (WHO, Substance
Abuse Department) and Jennifer
Hillebrand (WHO, Substance Abuse
Department) also edited the workbook series in later stages. Maristela
Monteiro (WHO, Substance Abuse
Department) provided editorial input throughout the development of this workbook. 3
WHO/MSD/MSB 00.2g
4
Evaluation of Psychoactive Substance Use Disorder Treatment
WHO/MSD/MSB 00.2g
Table of contents
Overview of
References: Lawrence Erlbaum Associates: San Francisco, 1994: 402-420. experience. Evaluation and Programme Planning, 1983, 6: 395-400. Evaluation and Programme Planning, 1989, 12:271-278. Programme Planning, 1990, 13: 119-124. Microfilms No. 7904220), 1979. patient satisfaction: Development of a general scale. Evaluation and Programme Planning, 1979, 2: 197-207. Evaluation and Programme Planning, 1983, 6: 237-245. instruments. Rockville, MA: National Institute on Alcohol Abuse and Alcoholism, 1985. 18 settings.Evaluation and Program- me Planning, 1981, 4: 139-150. (pp.31-51). New York: Haworth Press, 1988. Manual. National Institute on Drug Abuse, Rockville, MD, 1993. Programme Planning, 1983, 6: 299-314. Assessing the Client Satisfaction Questionnaire in English and Spanish. Hispanic Journal of Behavioural Science, 1984, 6: 385-396. Psychiatric Epidemiology, 1994, 29: 212-227. un service universitaire de psychologie. Canadian Journal of Behavioural Science, 1987, 19: 314-323. Nursing, 1993, 18: 246-259. 19, Cambridge University Press, Cambridge, 1993. No. 13-18082).